CoChat

Loss of Extracellular Signal-Regulated Kinase 1/2 in the Retinal Pigment Epithelium Leads to RPE65 Decrease and Retinal Degeneration

Open access

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index; 21 of the 46 sources its claims cite were checked for support.

Abstract

Recent work suggested that the activity of extracellular signal-regulated kinase 1/2 (ERK1/2) is increased in the retinal pigment epithelium (RPE) of age-related macular degeneration (ARMD) patients and therefore could be an attractive therapeutic target. Notably, ERK1/2 pathway inhibitors are used in cancer therapy, with severe and noncharacterized ocular side effects. To decipher the role of ERK1/2 in RPE cells, we conditionally disrupted the Erk1 and Erk2 genes in mouse RPE. The loss of ERK1/2 activity resulted in a significant decrease in the level of RPE65 expression, a decrease in ocular retinoid levels concomitant with low visual function, and a rapid disorganization of RPE cells, ultimately leading to retinal degeneration. Our results identify the ERK1/2 pathway as a direct regulator of the visual cycle and a critical component of the viability of RPE and photoreceptor cells. Moreover, our results caution about the need for a very fine adjustment of kinase inhibition in cancer or ARMD treatment in order to avoid ocular side effects.

Overview

CoChat Summary

TL;DR

RPE-specific deletion of ERK1/2 in adult mice causes early RPE65 downregulation via reduced C-FOS/FRA-1 binding to an AP-1 site, retinoid depletion, and progressive RPE/retinal degeneration. These findings argue that ERK1/2 inhibition proposed for ARMD treatment must be reevaluated because ERK1/2 is needed for RPE maintenance and visual function.

Key findings

  • RPE-DKO mice showed fundus depigmentation, significant reduction of all retinal and choroidal layers by OCT at 4 months, and impaired ERG at 2 months, with absence or severe reduction of a and b waves under scotopic 50 mcd s/m² and absence of stimulation under photopic 10 mcd s/m².
  • Ocular retinoids were depleted: dark-adapted retinas had decreases of more than half in 11-*cis*-retinal and all-*trans*-retinal, choroidal retinyl esters were significantly reduced, and light-exposed all-*trans*-retinol and retinyl esters were significantly lower than controls.
  • Retinal degeneration was severe: ONL and INL thicknesses were reduced by 50% after 2 months and up to 70% after 4 months; GNAT2 was reduced by more than 60% at 4 months; qPCR cone markers decreased 60–80% at 4 months; at 1 year the ONL disappeared, the INL was drastically thinned, and no cone or rod staining remained.
  • Mechanistically, RPE65 mRNA and protein were decreased by about 50% at 1 month and already at 2 weeks; LRAT was mislocalized; the RPE65 promoter AP-1 site was required for U0126 sensitivity; and C-FOS and FRA-1 binding/protein levels were reduced in RPE-DKO RPE and after ERK1/2 inhibition.

Methods

  • Mice: *Erk1*−/−; *Erk2* f/f mice were crossed with VMD2-rtTA/TRE-Cre mice; two intraperitoneal injections of 10 μg doxycycline 1 week apart at 2 months induced RPE-specific *Erk2* deletion (RPE-DKO), while controls received PBS. Analyses were at 2 weeks, 1 month, 2 months, 4 months, or 1 year after injection.
  • Functional and structural assays: fundus photography, OCT, scotopic and photopic ERG, immunohistochemistry, TUNEL, electron microscopy, flat-mount RPE-choroid analysis, Western blot, qPCR, and HPLC retinoid measurements.
  • Cell and molecular assays: HEK293T/HEK293 and ARPE19 cells; luciferase reporter assays with RPE65 or LRAT promoter constructs and an AP-1-deleted RPE65 construct; treatment with U0126 (10 nM) or PD0325901 (2 μM) for 24 h; AP-1 binding ELISA and EMSA.

Limitations

  • Stated: The authors cannot exclude that other regulatory elements close to the AP-1 site were also deleted from the RPE65 promoter reporter, which could explain the low promoter activity observed without the AP-1 sequence.
  • Stated: They cannot totally exclude that ERK1/2 was also depleted in some IPL vessels because of ectopic Cre expression in IPL vessels (but not choroidal vessels) in certain mice, which may impact INL degeneration; further analyses are required to decipher the mechanisms leading to INL degeneration.
  • Evident from the text: Some supporting observations are reported as data not shown (e.g., STRA6 decrease and control retinal degeneration data), and the GNAT1 immunostaining decrease was not confirmed by qPCR or Western blot because the GNAT1/tubulin ratio was unchanged.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1128/mcb.00295-17

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

FIG 1 Generation and characterization of CTL and RPE-DKO mice. (A) tdTomato fluorescence of cryostat sections of fixed whole-mount eyes from Cre/tdTomato mice injected with either PBS or doxycycline (Dox). (B) Constructs used to generate Erk1-KO and Erk2 conditional mice (Erk1−/− Erk2f/f) and primers used to genotype the mice. Wt, wild type. (C) Representative genotyping of Erk1+/−; Erk2+/f mice (lane 1); Erk1−/−; Erk2f/f mice, called CTL mice (lane 2); and VMD2-rtTA/TRE-Cre; Erk1−/−; Erk2Δ/Δ mice, called RPE-DKO mice, when injected with Dox (lane 3). (D) The specific loss of Erk2 in the RPE is confirmed by the delta fragment present in genomic DNA isolated from RPE cells from Erk1+/−; Erk2+/f mice (lane 1), Erk1−/−; Erk2f/f mice, called CTL mice (lane 2); and VMD2-rtTA/TRE-Cre; Erk1−/−; Erk2Δ/Δ mice, called RPE-DKO mice, when injected with Dox (lane 3). (E) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 month, immunostained as indicated. (F) Western blot analysis of ERK1/2 expression in RPE protein lysates from CTL and RPE-DKO mice at 1 month. The ARPE19 protein lysate is used as a positive control for ERK1 expression.
FIG 1 Generation and characterization of CTL and RPE-DKO mice. (A) tdTomato fluorescence of cryostat sections of fixed whole-mount eyes from Cre/tdTomato mice injected with either PBS or doxycycline (Dox). (B) Constructs used to generate Erk1-KO and Erk2 conditional mice (Erk1−/− Erk2f/f) and primers used to genotype the mice. Wt, wild type. (C) Representative genotyping of Erk1+/−; Erk2+/f mice (lane 1); Erk1−/−; Erk2f/f mice, called CTL mice (lane 2); and VMD2-rtTA/TRE-Cre; Erk1−/−; Erk2Δ/Δ mice, called RPE-DKO mice, when injected with Dox (lane 3). (D) The specific loss of Erk2 in the RPE is confirmed by the delta fragment present in genomic DNA isolated from RPE cells from Erk1+/−; Erk2+/f mice (lane 1), Erk1−/−; Erk2f/f mice, called CTL mice (lane 2); and VMD2-rtTA/TRE-Cre; Erk1−/−; Erk2Δ/Δ mice, called RPE-DKO mice, when injected with Dox (lane 3). (E) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 month, immunostained as indicated. (F) Western blot analysis of ERK1/2 expression in RPE protein lysates from CTL and RPE-DKO mice at 1 month. The ARPE19 protein lysate is used as a positive control for ERK1 expression.CC BY · PubMed Central
FIG 2 Loss of ERK1/2 in the RPE leads to vision impairment. (A) Representative fundus images of CTL and RPE-DKO mice at 2 or 4 months. (B) Representative OCT images of CTL and RPE-DKO mice at 4 months. (C) Graphs of the scotopic (n = 10) and photopic (n = 4) ERG responses (b wave) of CTL and RPE-DKO mice at 2 months. (*, P < 0.05; **, P < 0.001). The right panel shows the scotopic (50 mcd s/m2) and photopic (10 mcd s/m2) ERG responses of CTL and RPE-DKO mice. (D) Chromatographs and quantification of retinoids (retinol [ROL] and retinal [RAL]) measured in the retina and in the RPE-choroid from mice at 1 month, which were dark adapted for 16 h, or measured in whole eyes (containing the retina, RPE, and choroid) from mice (same conditions) exposed to 1,000 mA of light for 2 h.
FIG 2 Loss of ERK1/2 in the RPE leads to vision impairment. (A) Representative fundus images of CTL and RPE-DKO mice at 2 or 4 months. (B) Representative OCT images of CTL and RPE-DKO mice at 4 months. (C) Graphs of the scotopic (n = 10) and photopic (n = 4) ERG responses (b wave) of CTL and RPE-DKO mice at 2 months. (*, P < 0.05; **, P < 0.001). The right panel shows the scotopic (50 mcd s/m2) and photopic (10 mcd s/m2) ERG responses of CTL and RPE-DKO mice. (D) Chromatographs and quantification of retinoids (retinol [ROL] and retinal [RAL]) measured in the retina and in the RPE-choroid from mice at 1 month, which were dark adapted for 16 h, or measured in whole eyes (containing the retina, RPE, and choroid) from mice (same conditions) exposed to 1,000 mA of light for 2 h.CC BY · PubMed Central
FIG 3 Loss of ERK1/2 in the RPE leads to photoreceptor degeneration. (A) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 or 4 months, immunostained against different rod and cone markers, as indicated. (B) Flat-mount retinal preparation from CTL and RPE-DKO mice at 4 months, immunostained as indicated. (C) Outer nuclear layer (ONL) and inner nuclear layer (INL) lengths measured manually by using ImageJ. Data represent means ± standard errors of the means of results from four independent experiments. *, P < 0.05. (D) GNAT1 and cone arrestin stainings from CTL and RPE-DKO mice at 1 month. The presence of both photoreceptor markers was observed in the RPE of RPE-DKO mice (white arrows). (E) TUNEL staining of cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 months.
FIG 3 Loss of ERK1/2 in the RPE leads to photoreceptor degeneration. (A) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 or 4 months, immunostained against different rod and cone markers, as indicated. (B) Flat-mount retinal preparation from CTL and RPE-DKO mice at 4 months, immunostained as indicated. (C) Outer nuclear layer (ONL) and inner nuclear layer (INL) lengths measured manually by using ImageJ. Data represent means ± standard errors of the means of results from four independent experiments. *, P < 0.05. (D) GNAT1 and cone arrestin stainings from CTL and RPE-DKO mice at 1 month. The presence of both photoreceptor markers was observed in the RPE of RPE-DKO mice (white arrows). (E) TUNEL staining of cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 months.CC BY · PubMed Central
FIG 4 Decreases of outer nuclear layer (ONL), outer segment (OS), and inner segment (IS) lengths from the start of degeneration to complete absence in RPE-DKO mice at 1 year. (A) Electron microscopy images of retina-RPE layers from CTL and RPE-DKO mice at 2 or 4 months. The bottom panel is a magnification of the OS layer of photoreceptors (PR). (B) Measurement of ONL, OS, and IS from electron microscopy images. Data represent means ± standard errors of the means of results from 3 experiments. **, P < 0.008. (C) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 year, immunostained as indicated.
FIG 4 Decreases of outer nuclear layer (ONL), outer segment (OS), and inner segment (IS) lengths from the start of degeneration to complete absence in RPE-DKO mice at 1 year. (A) Electron microscopy images of retina-RPE layers from CTL and RPE-DKO mice at 2 or 4 months. The bottom panel is a magnification of the OS layer of photoreceptors (PR). (B) Measurement of ONL, OS, and IS from electron microscopy images. Data represent means ± standard errors of the means of results from 3 experiments. **, P < 0.008. (C) Cryostat sections of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 year, immunostained as indicated.CC BY · PubMed Central
FIG 5 Loss of ERK1/2 in the RPE causes specific reductions in the levels of cone markers. (A) Representative images and quantification graphs of retinal protein lysates from CTL and RPE-DKO mice at 1, 2, or 4 months. Data represent means ± standard errors of the means of results from 5 independent experiments (*, P < 0.02; **, P < 0.001). (B) Quantification graphs for qPCR performed on retinal extracts from CTL and RPE-DKO mice at 1, 2, or 4 months. RL8 was used as an internal control to normalize RNA expression. Results are expressed as a percentage of the value for CTL mice and as means ± standard errors of the means of results from 4 independent experiments (*, P < 0.05; **, P < 0.003).
FIG 5 Loss of ERK1/2 in the RPE causes specific reductions in the levels of cone markers. (A) Representative images and quantification graphs of retinal protein lysates from CTL and RPE-DKO mice at 1, 2, or 4 months. Data represent means ± standard errors of the means of results from 5 independent experiments (*, P < 0.02; **, P < 0.001). (B) Quantification graphs for qPCR performed on retinal extracts from CTL and RPE-DKO mice at 1, 2, or 4 months. RL8 was used as an internal control to normalize RNA expression. Results are expressed as a percentage of the value for CTL mice and as means ± standard errors of the means of results from 4 independent experiments (*, P < 0.05; **, P < 0.003).CC BY · PubMed Central
FIG 6 Loss of ERK1/2 in the RPE leads to massive ultrastructural changes in RPE-DKO mice at 1 month. (A) Representative electron microscopy images showing different retinal and RPE cell layers (B, Bruch's membrane; RPE, retinal pigment epithelium; OS, outer segment; IS, inner segment; ONL, outer nuclear layer). (B) Representative electron microscopy image of Bruch's membrane (Mbre) and the underlying RPE cells and measurement of the length of Bruch's membrane (*, P < 0.0001). (C) Representative electron microscopy images of the RPE cell layer and the underlying OS of the PR, measurement of the RPE length, and quantification of the area of mitochondria (stars, mitochondria) (*, P < 0.015). (D) Electron microscopy images showing the accumulation of membrane-enriched phagolysosomes in the RPE of RPE-DKO mice in comparison to CTL mice (white arrows). (E and F) RPE flat mounts from CTL and RPE-DKO mice at 2 months, immunostained against phalloidin and counterstained with DAPI.
FIG 6 Loss of ERK1/2 in the RPE leads to massive ultrastructural changes in RPE-DKO mice at 1 month. (A) Representative electron microscopy images showing different retinal and RPE cell layers (B, Bruch's membrane; RPE, retinal pigment epithelium; OS, outer segment; IS, inner segment; ONL, outer nuclear layer). (B) Representative electron microscopy image of Bruch's membrane (Mbre) and the underlying RPE cells and measurement of the length of Bruch's membrane (*, P < 0.0001). (C) Representative electron microscopy images of the RPE cell layer and the underlying OS of the PR, measurement of the RPE length, and quantification of the area of mitochondria (stars, mitochondria) (*, P < 0.015). (D) Electron microscopy images showing the accumulation of membrane-enriched phagolysosomes in the RPE of RPE-DKO mice in comparison to CTL mice (white arrows). (E and F) RPE flat mounts from CTL and RPE-DKO mice at 2 months, immunostained against phalloidin and counterstained with DAPI.CC BY · PubMed Central
FIG 7 ERK1/2 directly regulates RPE65 expression. (A) Cryostat section of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 month, immunostained as indicated. (B) Cryostat section of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 weeks, immunostained as indicated. (C) qPCR analysis of mRNAs for the genes indicated, extracted from the RPE-choroids of CTL and RPE-DKO mice at 1 month. RL8 was used as an internal control to normalize RNA expression. Results are expressed as a percentage of the value for CTL mice and as means ± standard errors of the means of results from 3 retinas. *, P < 0.03. (D) Representative immunoblot and quantification of RPE protein lysates from CTL and RPE-DKO mice at 1 month, immunoblotted as indicated. **, P < 0.0002 (n = 5). (E) Luciferase assay for both RPE65 and LRAT promoters. HEK293 cells were transfected and treated as indicated. Luciferase fluorescence was normalized to β-Gal fluorescence. Data represent means ± standard errors of the means of results from 4 independent experiments. *, P < 0.05 versus pGL2-Basic-RPE65; #, P < 0.05 versus pGL2-Basic. (F) EMSA of the AP-1 complex in nuclei from ARPE19 cells treated or not with U0126. AP-1 DNA binding analysis of nuclear extracts of ARPE19 cells treated with either U0126 or PD0325901. Data represent means ± standard errors of the means of results from 3 independent experiments, expressed as a percentage of the value for the control. *, P < 0.02; **, P < 0.002. (G) AP-1 DNA binding analysis of whole-cell extracts from mice at 1 month. Data represent means ± standard errors of the means of results from 3 independent experiments, expressed as a percentage of the control. *, P < 0.015; **, P < 0.002 (n = 6). Also shown is a representative immunoblot of RPE protein lysates from CTL and RPE-DKO mice at 1 month, showing the expression of C-FOS and FRA-1; tubulin was used as a control.
FIG 7 ERK1/2 directly regulates RPE65 expression. (A) Cryostat section of fixed whole-mount eyes from CTL and RPE-DKO mice at 1 month, immunostained as indicated. (B) Cryostat section of fixed whole-mount eyes from CTL and RPE-DKO mice at 2 weeks, immunostained as indicated. (C) qPCR analysis of mRNAs for the genes indicated, extracted from the RPE-choroids of CTL and RPE-DKO mice at 1 month. RL8 was used as an internal control to normalize RNA expression. Results are expressed as a percentage of the value for CTL mice and as means ± standard errors of the means of results from 3 retinas. *, P < 0.03. (D) Representative immunoblot and quantification of RPE protein lysates from CTL and RPE-DKO mice at 1 month, immunoblotted as indicated. **, P < 0.0002 (n = 5). (E) Luciferase assay for both RPE65 and LRAT promoters. HEK293 cells were transfected and treated as indicated. Luciferase fluorescence was normalized to β-Gal fluorescence. Data represent means ± standard errors of the means of results from 4 independent experiments. *, P < 0.05 versus pGL2-Basic-RPE65; #, P < 0.05 versus pGL2-Basic. (F) EMSA of the AP-1 complex in nuclei from ARPE19 cells treated or not with U0126. AP-1 DNA binding analysis of nuclear extracts of ARPE19 cells treated with either U0126 or PD0325901. Data represent means ± standard errors of the means of results from 3 independent experiments, expressed as a percentage of the value for the control. *, P < 0.02; **, P < 0.002. (G) AP-1 DNA binding analysis of whole-cell extracts from mice at 1 month. Data represent means ± standard errors of the means of results from 3 independent experiments, expressed as a percentage of the control. *, P < 0.015; **, P < 0.002 (n = 6). Also shown is a representative immunoblot of RPE protein lysates from CTL and RPE-DKO mice at 1 month, showing the expression of C-FOS and FRA-1; tubulin was used as a control.CC BY · PubMed Central

Verification

Claims the paper makes

19 Valid · 1 Not valid · 16 Not checked · 72 Own results and interpretations

42 more claims · 2 with their cited sources checked

Create a free account to see all 108 claims and every source verdict.

See all claims — free account
  • Probably not a substantial claim. 26
  • It may state two separate claims as one. 46

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

1 of 1

Citations

Cites

Cited by

See all 20

Metadata

Authors
Pyakurel, A., Balmer, D., Saba-El-Leil, M. K., Kizilyaprak, C., Daraspe, J., Humbel, B. M., Voisin, L., Le, Y. Z., von Lintig, J., Meloche, S., & Roduit, R.
Affiliations
  • Institut de Recherche en Opthalmologie (CH)
  • Institute for Research in Immunology and Cancer (CA)
  • University of Lausanne (CH)
  • University of Oklahoma Health Sciences Center (US)
  • Department of Pharmacology, School of Medicine, Case Western Reserve University
Corresponding author
Roduit, Raphaël
Venue
Molecular and Cellular Biology
Published
2017-12-01
Volume
37
Issue
24
ISSN
  • 0270-7306 (ISSN-L)
  • 1098-5549
OpenAlex
W2767028946
Cited by
20
References
76
Citations by year
2025: 2 · 2024: 8 · 2023: 5 · 2021: 1 · 2020: 4
FWCI
0.45
Type
journal article
Language
en
Open access
Locations
  • Molecular and Cellular Biology (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • SERVAL (Université de Lausanne) (publishedVersion, cc-by)
  • IRIS (submittedVersion, cc-by)
  • SERVAL (Université de Lausanne) (submittedVersion, other-oa)
Funders
  • Gelbert Foundation
  • Art & Vie Foundation
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Development and Disorders
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Health Sciences › Medicine › Ophthalmology › Drug-Induced Ocular Toxicity
Keywords
ERK signaling, retinal pigment epithelium, RPE65, retinal degeneration, age-related macular degeneration, visual cycle, conditional gene disruption, kinase inhibitors, ocular adverse effects
MeSH terms
Retinoid Isomerohydrolase, Animals, Macular Degeneration, Retina, Retinoids, Mice, Knockout, cis-trans-Isomerases, Mitogen-Activated Protein Kinase 1, MAP Kinase Signaling System, Models, Animal, Mice, Retinal Pigment Epithelium

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.